Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zimmer Biomet Holdings's quarterly finished goods
declined
from Dec. 2025 (R$9,996 Mil) to Mar. 2026 (R$9,305 Mil) and
declined
from Mar. 2026 (R$9,305 Mil) to Jun. 2026 (R$9,264 Mil).
Zimmer Biomet Holdings's annual finished goods
increased
from Dec. 2023 (R$8,973 Mil) to Dec. 2024 (R$10,809 Mil) but then
declined
from Dec. 2024 (R$10,809 Mil) to Dec. 2025 (R$9,996 Mil).
Zimmer Biomet Holdings Inventories, Finished Goods Historical Data
* Premium members only.
The historical data trend for Zimmer Biomet Holdings's Inventories, Finished Goods can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Inventories, Finished Goods of R$9,264 Mil mean?
Zimmer Biomet Holdings (BSP:Z1BH34) has a Inventories, Finished Goods of R$9,264 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' Inventories, Finished Goods too high?
Zimmer Biomet Holdings' current Inventories, Finished Goods is R$9,264 Mil. Overall, Zimmer Biomet Holdings has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Inventories, Finished Goods compare to STE and PEN?
Zimmer Biomet Holdings' Inventories, Finished Goods of R$9,264 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Inventories, Finished Goods is R$9,264 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (BSP:Z1BH34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$154.55, compared to a current price of R$121.92 — trading 21.1% below its estimated fair value. The current Inventories, Finished Goods is R$9,264 Mil. Zimmer Biomet Holdings' overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Zimmer Biomet Holdings (BSP:Z1BH34), the current Inventories, Finished Goods is R$9,264 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (BSP:Z1BH34) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of R$121.92 is trading 21.1% below its estimated GF Value™ of R$154.55.
GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.
Key valuation signals for BSP:Z1BH34:
Inventories, Finished Goods: R$9,264 Mil
GF Value™: R$154.55 vs. price of R$121.92 (21.1% below fair value)
No single metric tells the full story. See the BSP:Z1BH34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
62GF Score
Get the complete analysis for BSP:Z1BH34
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:Z1BH34 has been successfully added to your 
